Abstract:Objective: To estimate the incidence and mortality of cervical cancer in China based on the cancer registration data in 2015, collected by the National Central Cancer Registry (NCCR). Methods: There were 501 cancer registries that submitted data to the NCCR, whose data were the basis for estimating the incidence and mortality of cervical cancer in China in 2015. After evaluating the data quality, 368 registries' data were accepted for the analysis and stratified by area (urban/rural) and age group. Combined with data on the national population in 2015, the nationwide incidence and mortality of cervical cancer were estimated. Cervical Cancer cases of 22 cancer registries were applied for temporal trends from 2000 to 2015. The Chinese population census in 2000 and Segi's population were used to calculate age-standardized incidence and mortality rates. Results: An estimated 111,000 new cases were attributed to cervical cancer in China in 2015, accounting for 6.24% of all female new cancer cases in that year in China. The crude rate (CR) of incidence and age-standardized incidence rates by the China standard population (ASIRC) and by Segi's world standard population (ASIRW) of cervical cancer were 16.56/100,000, 11.78/100,000, and 10.86/100,000, respectively. The cumulative incidence rate from birth to 74 years old was 1.15%, whereas the calculation of incidence rates over the truncated age range of 35-64 years by Segi's world standard population (T-ASIRW) was 27.66/100,000. The estimates of cervical cancer deaths were about 33,800 and 3.94% of all female cancer-related deaths in China in 2015, with a crude mortality rate of 5.04/100,000. The age-standardized mortality rates adjusted by the Chinese standard population (ASMRC) and by world Segi's population (ASMRW) were 3.29/100,000 and 3.15/100,000, respectively, with a cumulative mortality rate (0-74 years old) of 0.35%. Both the incidence and mortality were higher in rural than in urban areas. The age-specific cervical cancer incidence significantly increased with age, particularly after age 25 years, and peaked at 50-54 years old, whereas age-specific mortality increased rapidly after 35 years old, peaking at 80-84 years old. The age-standardized incidence rates increased by about 8.6 (95% CI: 6.9, 10.3) per year during the period of 2000-2015. The age at diagnosis of patients with cervical cancer tended to be younger. In rural areas, the mean age at diagnosis decreased about 3.22 years from 2000 to 2015 (β = -0.33, P < 0.001). Conclusions: China has a high burden of cervical cancer and important disparities among different regions. Especially in the middle and western areas and rural areas, cervical cancer is a serious issue in women's health, and prevention strategies need to be enhanced. Prevention and control strategies need to be enhanced and implemented with reference to local status, such as human papillomavirus (HPV) vaccination and screening programs.

Trend of Disease Burden on Nasopharyngeal Carcinoma in Cangwu County of Guangxi from 2014 to 2018

The Global Burden of Nasopharyngeal Carcinoma from 2009 to 2019: an Observational Study Based on the Global Burden of Disease Study 2019.

Long-term Trends in the Burden of Nasopharyngeal Carcinoma in China: A Comprehensive Analysis from 1990 to 2021 and Projections to 2030 Based on the Global Burden of Disease Study 2021

Trends in Incidence and Mortality of Nasopharyngeal Carcinoma over a 20–25 Year Period (1978/1983–2002) in Sihui and Cangwu Counties in Southern China

Global burdens of nasopharyngeal carcinoma in children and young adults and predictions to 2040

Long-term trends of nasopharyngeal carcinoma mortality in China from 2006 to 2020 by region and sex: an age-period-cohort analysis

Nasopharyngeal carcinoma incidence and mortality in China, 2013

Demographics and Economic Burden of Nasopharyngeal Carcinoma Inpatients

Nasopharyngeal Cancer Incidence and Mortality in 185 Countries in 2020 and the Projected Burden in 2040: Population-Based Global Epidemiological Profiling

Mortality of major cancers in Guangxi, China: sex, age and geographical differences from 1971 and 2005

Global, regional and national burdens of Nasopharynx cancer in the adolescents and young adults from 1990 to 2019 and its predictions

[Spatial distribution of cancer-related burden in Guangzhou from 2010 to 2013]

PCN198 THE BURDEN OF ESOPHAGEAL CANCER IN CHINA FROM 2013 TO 2030: A DYNAMIC COHORT MODELING STUDY

An Analysis of the Malignancies Induced Life Lost in Nangang District, Harbin,1992～2003

Time trends of major cancers incidence and mortality in Guangzhou, China 2004–2015: A Joinpoint and Age–Period–Cohort Analysis

Nasopharyngeal cancer risk assessment by country or region worldwide from 1990 to 2019

Burden of All Cancers Along With Attributable Risk Factors in China From 1990 to 2019: Comparison With Japan, European Union, and USA

Cervical cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with England and India based on the global burden of disease study 2019

Incidence and mortality of cervical cancer in China in 2015

Chinese and global burdens of gastric cancer from 1990 to 2019

Effects of ambient temperature, relative humidity and absolute humidity on risk of nasopharyngeal carcinoma in China